Skip to main content
Caplight Logo









TRACER Europe B.V.

TRACER Europe B.V.

Private
GroningenHealthcare & Life Scienceshttps://www.tracercro.com/

Company Overview

TRACER Europe B.V. is a clinical research organization that specializes in fast-track solutions for testing innovative biologic medicines through nuclear and optical molecular imaging methodologies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Imaging, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

clinical research organizationCROphase 0 clinical trialsfirst-in-human trialsmolecular imagingmicrodosingdrug developmentpharmacokineticsbiodistribution analysischemistry manufacturing controlCMCregulatory consultancydrug de-riskingclinical translationproof of concept

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TRACER Europe B.V. Comparables

Compare TRACER Europe B.V. with similar companies based on industry and business-model similarity.

TRACER Europe B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH
80%
MITRO Biotech Co., Ltd.
78%
3D-PharmXchange
74%

TRACER Europe B.V. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Ari Aminetzah

Chief Business Officer & Co-Founder

Founding Team

Go van Dam

Chief Executive Officer, Chief Executive Officer

Executive Team

TRACER Europe B.V. Investors

Notable investors and investment history

TRACER Europe B.V. investors
InvestorRounds
Nextgen VenturesEarly Funding
Noordelijke Ontwikkelings MaatschappijEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors increased 31% MoM, reaching 12K.

  • Jan 8, 2026

    Monthly visitors increased 56% MoM.

TRACER Europe B.V. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TRACER Europe B.V. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TRACER Europe B.V.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGroningen
Employee Range13
Year Founded2018
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?